Literature DB >> 28713040

Watching the gorilla and questioning delivery dogma.

Thomas J Anchordoquy1, Dmitri Simberg2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28713040      PMCID： PMC5662108          DOI： 10.1016/j.jconrel.2017.07.021

Source DB:  PubMed          Journal:  J Control Release        ISSN： 0168-3659            Impact factor:   9.776


× No keyword cloud information.
  64 in total

1.  Neutralising antibodies to interferon beta during the treatment of multiple sclerosis.

Authors:  G Giovannoni; F E Munschauer; F Deisenhammer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-11       Impact factor: 10.154

2.  BSA degradation under acidic conditions: a model for protein instability during release from PLGA delivery systems.

Authors:  Tia Estey; Jichao Kang; Steven P Schwendeman; John F Carpenter
Journal:  J Pharm Sci       Date:  2006-07       Impact factor: 3.534

3.  Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.

Authors:  Nicole Casadevall; Joelle Nataf; Beatrice Viron; Amir Kolta; Jean-Jacques Kiladjian; Philippe Martin-Dupont; Patrick Michaud; Thomas Papo; Valerie Ugo; Irene Teyssandier; Bruno Varet; Patrick Mayeux
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245

4.  Stabilization of proteins encapsulated in injectable poly (lactide- co-glycolide)

Authors:  G Zhu; S R Mallery; S P Schwendeman
Journal:  Nat Biotechnol       Date:  2000-01       Impact factor: 54.908

5.  Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis.

Authors:  Gerrit Jan Wolbink; Marijn Vis; Willem Lems; Alexandre E Voskuyl; Els de Groot; Michael T Nurmohamed; Steven Stapel; Paul P Tak; Lucien Aarden; Ben Dijkmans
Journal:  Arthritis Rheum       Date:  2006-03

Review 6.  A comparison of liposomal formulations of doxorubicin with drug administered in free form: changing toxicity profiles.

Authors:  D N Waterhouse; P G Tardi; L D Mayer; M B Bally
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 7.  Significance of neutralizing antibodies to interferon beta during treatment of multiple sclerosis: expert opinions based on the Proceedings of an International Consensus Conference.

Authors:  H-P Hartung; F Munschauer; H Schellekens
Journal:  Eur J Neurol       Date:  2005-08       Impact factor: 6.089

8.  Skin toxic effects of polyethylene glycol-coated liposomal doxorubicin.

Authors:  M Lotem; A Hubert; O Lyass; M A Goldenhersh; A Ingber; T Peretz; A Gabizon
Journal:  Arch Dermatol       Date:  2000-12

Review 9.  Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies.

Authors:  Alberto Gabizon; Hilary Shmeeda; Yechezkel Barenholz
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

10.  Degradation kinetics of high molecular weight poly(L-lactide) microspheres and release mechanism of lipid:DNA complexes.

Authors:  Mayank M Patel; Michelle G Zeles; Mark C Manning; Theodore W Randolph; Thomas J Anchordoquy
Journal:  J Pharm Sci       Date:  2004-10       Impact factor: 3.534
View more
  7 in total

1.  The Potential of Exosomes From Cow Milk for Oral Delivery.

Authors:  Jamie L Betker; Brittany M Angle; Michael W Graner; Thomas J Anchordoquy
Journal:  J Pharm Sci       Date:  2018-11-20       Impact factor: 3.534

Review 2.  It's All in the Delivery: Designing Hydrogels for Cell and Non-viral Gene Therapies.

Authors:  Richard L Youngblood; Norman F Truong; Tatiana Segura; Lonnie D Shea
Journal:  Mol Ther       Date:  2018-08-04       Impact factor: 11.454

3.  The Use of Lactose as an Alternative Coating for Nanoparticles.

Authors:  Jamie L Betker; Thomas J Anchordoquy
Journal:  J Pharm Sci       Date:  2020-01-28       Impact factor: 3.534

4.  The Effect of Repeat Administration of Lipoplexes on Gene Delivery, Biodistribution, and Cytokine Response in Immunocompetent Tumor-Bearing Mice.

Authors:  Jamie L Betker; Thomas J Anchordoquy
Journal:  J Pharm Sci       Date:  2021-12-18       Impact factor: 3.784

5.  Nanoparticle uptake by circulating leukocytes: A major barrier to tumor delivery.

Authors:  Jamie L Betker; Dallas Jones; Christine R Childs; Karen M Helm; Kristina Terrell; Maria A Nagel; Thomas J Anchordoquy
Journal:  J Control Release       Date:  2018-07-17       Impact factor: 9.776

Review 6.  Revisiting the outstanding questions in cancer nanomedicine with a future outlook.

Authors:  M S Sudheesh; K Pavithran; Sabitha M
Journal:  Nanoscale Adv       Date:  2021-12-22

7.  Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles.

Authors:  Vivian P Vu; Geoffrey B Gifford; Fangfang Chen; Halli Benasutti; Guankui Wang; Ernest V Groman; Robert Scheinman; Laura Saba; Seyed Moein Moghimi; Dmitri Simberg
Journal:  Nat Nanotechnol       Date:  2019-01-14       Impact factor: 39.213
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.